Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,849.00    -8.00 (-0.43%)
Bid:
1,856.00
Ask:
1,858.00
Spread: 2.00 (0.108%)
Market Cap: £5.91b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Completion of $275m share repurchase programme

22 Dec 2025 07:00

RNS Number : 3632M
Hiscox Ltd
22 December 2025
 

Completion of $275 million share repurchase programme

 

 

Hamilton, Bermuda (22 December 2025) - Hiscox Ltd ("Hiscox" or the "Company") today announces that, further to the share repurchase programme announced on 27 February 2025 to buy back its ordinary shares of 6.5 pence each ("Ordinary Shares") for a maximum aggregate consideration of $175 million, and subsequently increased on 6 August 2025 to $275 million (the "Programme"), the Company completed the second and final tranche of the Programme on 19 December 2025.

 

Across the Programme the Company purchased 15,894,323 Ordinary Shares between 27 February 2025 and 19 December 2025, pursuant to the agreements with Peel Hunt LLP and Citigroup Global Markets Limited ("Citigroup"), totalling $275.0 million (excluding expenses).

 

Hiscox confirms it has now successfully completed the $275 million Programme.

 

ENDS

 

For further information

 

Investors and analysts

Yana O'Sullivan, Director of Investor Relations, London +44 (0)20 3321 5598

Marc Wetherhill, Group Company Secretary, Bermuda +1 441 278 8300

 

Media

Eleanor Orebi Gann, Group Director of Communications, London +44 (0)20 7081 4815

Simone Selzer, Brunswick +44 (0)20 7404 5959

 

Notes to editors

 

About The Hiscox Group

 

Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). Our ambition is to continue to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle. 

 

The Hiscox Group employs over 3,000 people in 13 countries, and has customers worldwide. Through the retail businesses in the USA, UK and Europe, we offer a range of specialist insurance products in commercial and personal lines. Internationally-traded, bigger-ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re & ILS.

 

Our values define our business, with a focus on people, courage, ownership and integrity. We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRBDDUXBDGUC
Date   Source Headline
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:30 amRNSSyndicates 33 and 6104 – results and estimates
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:01 amRNSAnnouncement of share repurchase programme
5th Mar 20247:00 amRNSFull Year Results
19th Feb 20245:48 pmRNSTR-1 Standard form-notification major shareholding
1st Feb 20244:34 pmRNSTotal Voting Rights
8th Jan 20243:07 pmRNSTotal Voting Rights
12th Dec 20234:44 pmRNSDirector/PDMR Shareholding
1st Dec 20234:40 pmRNSTotal Voting Rights
10th Nov 202311:30 amRNSSyndicates 33 and 6104 – results and estimates
8th Nov 20237:00 amRNSQ3 2023 Trading Statement
1st Nov 20235:20 pmRNSTotal Voting Rights
2nd Oct 20234:47 pmRNSTotal Voting Rights
27th Sep 20237:00 amRNSDivestment of DirectAsia
25th Sep 202312:30 pmRNSDirector/PDMR Shareholding
25th Sep 20239:00 amRNSApplication to be admitted to the Official List
12th Sep 20235:22 pmRNSAnnouncement of Scrip Reference Share Price
1st Sep 20237:00 amRNSDirector/PDMR Shareholding
11th Aug 20237:30 amRNSSyndicates 33 and 6104 - results and estimates
10th Aug 20237:00 amRNSDirector/PDMR Shareholding
4th Jul 20231:23 pmRNSTotal Voting Rights
21st Jun 20233:23 pmRNSDirector/PDMR Shareholding
16th Jun 202312:35 pmRNSDirector PDMR Shareholding
14th Jun 20231:19 pmRNSStandard form for notification of major holdings
13th Jun 20232:28 pmRNSDirector/PDMR Shareholding
9th Jun 20231:56 pmRNSApplication to be Admitted to Official List
9th Jun 202312:19 pmRNSApplication to be Admitted to Official List
8th Jun 20237:00 amRNSIFRS 17 restated results 2022
1st Jun 20235:10 pmRNSTotal Voting Rights
1st Jun 202312:12 pmRNSAnnouncement of Scrip Reference Share Price
30th May 20234:05 pmRNSDirector/PDMR Shareholding
30th May 20237:00 amRNSHiscox appoints Jonathan Bloomer Chair designate
23rd May 20233:26 pmRNSTR-1:Standard form-notification major shareholding
22nd May 202312:25 pmRNSTR-1:Standard form-notification major shareholding
15th May 20231:01 pmRNSSyndicates 33 and 6104 – results and estimates
12th May 20237:01 amRNSHiscox appoints new Independent Non Exec Director
12th May 20237:00 amRNSAGM RESULTS
11th May 20235:33 pmRNSTR-1 Standard form-notification major shareholding
9th May 202312:23 pmRNSTR-1:Standard form-notification major shareholding
4th May 20237:00 amRNSQ1 2023 Trading Statement
2nd May 20235:00 pmRNSTotal Voting Rights
5th Apr 20232:19 pmRNSDirector/PDMR Shareholding
3rd Apr 20234:08 pmRNSTotal Voting Rights
24th Mar 20231:30 pmRNSNotice of 2023 AGM & 2022 Annual Report & Accounts
22nd Mar 202311:03 amRNSDirector/PDMR Shareholding
9th Mar 20233:46 pmRNSDirector/PDMR Shareholding
9th Mar 20237:00 amRNSSyndicates 33 and 6104 – results and estimates

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.